Consensus review of the clinical utility of dna content cytometry in prostate cancer
Open Access
- 1 January 1993
- Vol. 14 (5) , 497-500
- https://doi.org/10.1002/cyto.990140508
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Guidelines for implementation of clinical DNA cytometryCytometry, 1993
- Histologic Grade, DNA Ploidy, and Intraglandular Tumor Extent as Indicators of Tumor Progression of Clinical Stage B Prostatic CarcinomaThe American Journal of Surgical Pathology, 1991
- Flow Cytometric DNA Analysis of Stage D2 Prostatic CarcinomaUrologia Internationalis, 1991
- Modal DNA Values and Estramustine-Binding Protein (EMBP) as Prognostic Markers in Prostatic CancerActa Oncologica, 1991
- Ploidy Level and Tumor Progression in Prostatic CarcinomaActa Oncologica, 1991
- Dna Flow Cytometry in Carcinoma of the Prostate for Diagnosis, Prognosis and Study of Tumor BiologyActa Oncologica, 1991
- Nuclear DNA Analysis: The Relevance of Ploidy, DNA Heterogeneity and Phases of the Cell Cycle in 329 Patients with Prostatic CarcinomaUrologia Internationalis, 1990
- Zonal Distribution of Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1988
- Relationship of DNA Content to Conventional Prognostic Factors in Clinically Localised Carcinoma of the ProstateBritish Journal of Urology, 1988
- Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcomeBritish Journal of Surgery, 1986